SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$2.57
-0.18 (-6.55%)
Open$2.72
Previous Close$2.75
Day High$2.78
Day Low$2.54
52W High$223.60
52W Low$2.31
Volume—
Avg Volume279.4K
Market Cap2.92M
P/E Ratio—
EPS$-55.60
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,310.1% upside
Current
$2.57
$2.57
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.24M | 2.11M | 2.20M |
| Net Income | -331,103 | -245,653 | -236,110 |
| Profit Margin | -14.8% | -11.6% | -10.7% |
| EBITDA | -455,957 | -486,512 | -478,296 |
| Free Cash Flow | -187,144 | -193,211 | -204,399 |
| Rev Growth | -3.1% | +9.8% | -1.4% |
| Debt/Equity | 0.51 | 0.41 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.53 | -1.09% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $361.16 | +0.17% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.13 | -0.16% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $494.74 | -0.98% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $628.06 | -0.59% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $297.43 | +1.33% | 69.3 | 39.97B |